Mastodon

Vitamin E (Capsules) Instructions for Use

ATC Code

A11HA03 (Tocopherol (Vitamin E))

Active Substance

Tocopherol (Ph.Eur. European Pharmacopoeia)

Clinical-Pharmacological Group

Vitamin preparation

Pharmacotherapeutic Group

Vitamins; other vitamin preparations

Pharmacological Action

Vitamin E. It has an antioxidant effect, participates in heme and protein biosynthesis, cell proliferation, tissue respiration, and other crucial processes of tissue metabolism, prevents erythrocyte hemolysis, prevents increased permeability and fragility of capillaries; stimulates the synthesis of proteins and collagen.

Pharmacokinetics

When taken orally, absorption is 50-80%; during absorption, it forms a complex with lipoproteins (intracellular carriers of tocopherol). The presence of bile acids is necessary for absorption.

It binds to alpha1– and beta-lipoproteins, partially to serum albumin. In case of protein metabolism disorders, transport is hindered. Cmax is reached after 4 hours. It is metabolized in the liver to derivatives with a quinone structure (some of them possess vitamin activity). It is excreted in breast milk. Accumulation is possible in premature and newborn infants. It is stored in the adrenal glands, pituitary gland, testes, adipose and muscle tissue, erythrocytes, and liver. More than 90% is excreted in the bile, 6% by the kidneys.

Indications

Treatment and prevention of hypovitaminosis. Conditions of convalescence after diseases accompanied by febrile syndrome, high physical exertion, old age, diseases of the ligamentous apparatus and muscles.

Climacteric autonomic disorders. Neurasthenia due to overwork, asthenic neurasthenic syndrome, primary muscular dystrophy, post-traumatic, post-infectious secondary myopathy. Degenerative and proliferative changes in the joints and ligamentous apparatus of the spine and large joints.

ICD codes

ICD-10 code Indication
E50-E64 Other types of nutritional deficiencies (E50-E64)
E56.0 Vitamin E deficiency
F48.0 Neurasthenia
G71.0 Muscular dystrophy
G72 Other myopathies
G73.4 Myopathy in infectious and parasitic diseases classified elsewhere
M15 Polyosteoarthritis
M19.9 Unspecified arthrosis
M42 Spinal osteochondrosis
M47 Spondylosis
M60 Myositis
M65 Synovitis and tenosynovitis
M70 Soft tissue disorders related to use, overuse, and pressure
M71 Other bursopathies
N95.1 Menopausal and other perimenopausal disorders
N95.3 States associated with artificial menopause
Z54 Convalescence
Z73.0 Burn-out
Z73.3 Stress, not elsewhere classified (physical and mental strain)
ICD-11 code Indication
5B58 Vitamin E deficiency
5B7Z Malnutrition, unspecified
6A8Z Affective disorders, unspecified
8C70.Z Muscular dystrophy, unspecified
8C8Z Secondary myopathies, unspecified
8D0Z Diseases of neuromuscular junction or muscles, unspecified
8D40.1 Neuropathy due to nutritional deficiency
FA05 Polyosteoarthritis
FA0Z Osteoarthritis, unspecified
FA85.Z Defects of vertebral end-plates, unspecified
FA8Z Degenerative disease of spine, unspecified
FB30 Infectious myositis
FB32 Other specified disorders of muscle
FB3Z Disorder of muscle, unspecified
FB40.Z Tenosynovitis, unspecified
FB50.1 Bursitis associated with use, overuse or pressure
FB50.Z Bursitis, unspecified
FB56.0 Granuloma of soft tissue due to foreign body, not elsewhere classified
GA30.00 Menopausal or climacteric states in women
GA30.3 States associated with artificial menopause
QB7Z Convalescence, unspecified
QD85 Burn-out
QE01 Stress, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take capsules orally, with water. Swallow whole; do not chew or crush.

For adult patients, the typical daily dose is 100-400 mg. Adjust the exact dose based on the specific clinical indication and patient condition.

For pediatric patients, use only age-appropriate formulations and doses. Determine the dose strictly based on the child’s age and body weight.

Administer the daily dose once or divide it into two or three smaller doses. Take with meals to enhance absorption, which requires the presence of dietary fats and bile.

The standard treatment course lasts from 2 to 8 weeks. The duration depends on the therapeutic response and the condition being treated.

For long-term use or repeated courses, periodically monitor blood clotting parameters and cholesterol levels.

Do not exceed the recommended daily dose without explicit medical supervision. High doses can induce vitamin A deficiency and increase the risk of bleeding when taken with anticoagulants.

Adverse Reactions

Allergic reactions: itching, skin hyperemia are possible.

From the digestive system: diarrhea, nausea, gastralgia, dyspepsia are possible.

Contraindications

Hypersensitivity to tocopherol; severe atherosclerosis of the coronary arteries, myocardial infarction, increased risk of thromboembolism; childhood – depending on the dosage form used.

With caution

Hypoprothrombinemia (against the background of vitamin K deficiency – may be enhanced at a vitamin E dose of more than 400 IU).

Use in Pregnancy and Lactation

The use of tocopherol during pregnancy and lactation (breastfeeding) is possible only as prescribed by a doctor.

Special Precautions

Prescribing vitamin E in high doses can cause vitamin A deficiency in the body.

With long-term use of tocopherol and/or the need for repeated courses of therapy, it is recommended to periodically monitor blood clotting parameters and blood cholesterol levels.

When taken simultaneously with other vitamin-mineral preparations containing fat-soluble vitamins A, D, and E, a doctor should be consulted.

Drug Interactions

With simultaneous use, vitamin E enhances the effect of glucocorticosteroids, NSAIDs, and cardiac glycosides.

Simultaneous use of vitamin E in a dose of more than 400 mg/day with anticoagulants (coumarin and indandione derivatives) increases the risk of hypoprothrombinemia and bleeding.

With simultaneous use, cholestyramine, colestipol, and mineral oils reduce the absorption of alpha-tocopherol acetate.

With simultaneous use of vitamin E with cyclosporine, the absorption of the latter increases.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Minskintercaps Up (Republic Of Belarus)

Dosage Form

Bottle OTC Icon Vitamin E Capsules 400 mg: 30 or 60 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
Tocopherol acetate 400 mg

10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (6) – cardboard packs.

Marketing Authorization Holder

Minskintercaps Up (Republic Of Belarus)

Dosage Form

Bottle OTC Icon Vitamin E Capsules 200 mg: 30 or 60 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
Tocopherol acetate 200 mg

10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (6) – cardboard packs.

Marketing Authorization Holder

Minskintercaps Up (Republic Of Belarus)

Dosage Forms

Bottle OTC Icon Vitamin E Capsules 200 mg
Capsules 400 mg

Dosage Form, Packaging, and Composition

Capsules

1 caps.
Tocopherol 200 mg

10 pcs. – blister packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – blister packs (6 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter


Capsules

1 caps.
Tocopherol 400 mg

10 pcs. – blister packs (3 pcs.) – cardboard packs (30 pcs.) – Over-the-Counter
10 pcs. – blister packs (6 pcs.) – cardboard packs (60 pcs.) – Over-the-Counter

Marketing Authorization Holder

Meligen FP, CJS (Russia)

Dosage Form

Bottle OTC Icon Vitamin E (Alpha-tocopherol acetate) Capsules 100 mg: 10, 20, 30, 40, 60, 500, 1000, 2000, 4000, 6000, 10000, 20000, 40000 or 60000 pcs.

Dosage Form, Packaging, and Composition

Capsules red in color, spherical; the contents of the capsules are an oily liquid from light yellow to dark yellow in color, without a rancid odor.

1 caps.
Vitamin E (tocopherol acetate) 100 mg

Excipients: sunflower oil – 100 mg.

Capsule shell composition: gelatin – 44.73 mg, glycerol – 14.67 mg, methylparaben – 0.29 mg, dye azorubine – 0.31 mg.

10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (2) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (4) – cardboard packs.
10 pcs. – blister packs (6) – cardboard packs.
10 pcs. – blister packs (50) – cardboard boxes (for hospitals).
10 pcs. – blister packs (100) – cardboard boxes (for hospitals).
10 pcs. – blister packs (200) – cardboard boxes (for hospitals).
10 pcs. – blister packs (400) – cardboard boxes (for hospitals).
10 pcs. – blister packs (600) – cardboard boxes (for hospitals).
10 pcs. – blister packs (1000) – cardboard boxes (for hospitals).
10 pcs. – blister packs (2000) – cardboard boxes (for hospitals).
10 pcs. – blister packs (4000) – cardboard boxes (for hospitals).
10 pcs. – blister packs (6000) – cardboard boxes (for hospitals).

TABLE OF CONTENTS